Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous mesenchymal stem cells (1 trial)
Graft vs Host Disease (Phase 2)
Trials (1 total)
Trial APIs (1 total)